Breast Cancer
News
Trastuzumab deruxtecan-related lung disease in MBC patients can occur anytime in first year
News
Endocrine therapy benefits in premenopausal breast cancer differ by molecular risk
News
Evolving strategies in sequencing for HER2+ MBC therapy
In a 12-month window, the FDA approved four agents targeting HER2-positive MBC.
News
New targeted treatments are major advances for HER2-positive breast cancer
News
GELATO trial: Chemoimmunotherapy may help in metastatic invasive lobular breast cancer
News
FDA panel votes against 2 cancer indications but backs 4 of 6
At a 3-day meeting, an FDA advisory group considered the accelerated approvals of six cancer indications for three immunotherapies.
News
FDA panel backs atezolizumab for mTNBC – at least for now
FDA advisers voted to keep in place an approval for atezolizumab in metastatic triple-negative breast cancer.
News
Cell-free DNA improves response prediction in breast cancer
Using cell-free DNA and MRI in combination improved prediction of pathological complete response.
Article
Treating metastatic TNBC: Where are we now?
News
PET predicts response to endocrine therapy in ER+ breast cancer